This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
KiOR: Catalyzing Clean Energy
Nanda, Ramana; Stuart, TobyCase HBS-809092-EEntrepreneurshipBiofuels start-up KiOR was developing a proprietary technology that had the potential to dramatically impact the emerging renewable energy landscape: a process that converted cellulosic biomass into "bio-crude," a hydrocarbon mixture with properties to those of crude oil. KiOR had been operating as a virtual organization, but with venture financing in place, founder and chief technology officer Paul O'Connor and the KiOR board needed to decide wh...Starting at €8.20
-
Tennant Company
Stuart, Toby; Applegate, Lynda M.; Weber, JamesCase HBS-810040-EEntrepreneurshipTennant, a leading producer of floor cleaning equipment, must determine how to create, finance, structure, staff, govern, measure and manage a new venture for developing a fundamentally new product line. In 2005, Tennant Company had developed an innovative, environmentally friendly, cleaning technology that could potentially revolutionize cleaning. Historically, Tennant was a producer of floor and carpet washing machines for industrial and commer...Starting at €8.20
-
Sirtris Pharmaceuticals: Living Healthier, Longer (Abridged)
Stuart, Toby; Webber, JamesCase HBS-813029-EEntrepreneurshipDescribes a set of key strategic decisions facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate?Starting at €8.20
-
Weizmann Institute - creando el futuro de la ciencia (A)
Pujol, Laia; Alvarez de Mon, Santiago; Davila, AntonioCase E-156Entrepreneurship, Innovation and Change, Leadership and People ManagementDesde su fundación en 1934 el Instituto Weizmann se ha revelado como uno de los centros de investigación más prestigiosos del mundo. Su campus a 40km de Tel Aviv es un marco idóneo para que el genio y creatividad humanos luzcan todo su potencial. Desde el punto de vista de la gestión de empresas, ¿cuál son algunas de las claves de su cultura corporativa? ¿Dónde radica el secreto de su excelencia? 1-Talento: rastreando el mundo en búsqueda de cabe...Starting at €8.20
-
Weizmann Institute - creando el futuro de la ciencia (B)
Pujol, Laia; Alvarez de Mon, Santiago; Davila, AntonioCase E-157Entrepreneurship, Innovation and Change, Leadership and People ManagementDesde su fundación en 1934 el Instituto Weizmann se ha revelado como uno de los centros de investigación más prestigiosos del mundo. Su campus a 40 km de Tel Aviv es un marco idóneo para que el genio y creatividad humanos luzcan todo su potencial. Desde el punto de vista de la gestión de empresas, ¿cuál son algunas de las claves de su cultura corporativa? ¿Dónde radica el secreto de su excelencia? 1-Talento: rastreando el mundo en búsqueda de cab...Starting at €5.74
-
Weizmann Institute - Creating the Future of Science (A)
Pujol, Laia; Alvarez de Mon, Santiago; Davila, AntonioCase E-156-EEntrepreneurship, Innovation and Change, Leadership and People ManagementSince its founding in 1934, the Weizmann Institute has stood out as one of the world's leading research centers. Its campus, 40 km from Tel Aviv, is an ideal environment for human creative genius to shine at its full potential. From the business management standpoint, what are some of the keys to its corporate culture? Where lies the secret behind its excellence? 1) Talent: Scouring the world in search of powerful minds hungry for knowledge. 2) T...Starting at €8.20
-
Sirtris Pharmaceuticals: Living Healthier, Longer
Stuart, Toby; Kiron, DavidCase HBS-808112-EEntrepreneurshipDescribes a set of key strategic decisions facing the scientific founder and CEO of a promising, Early stage bio-pharmaceuticals company.l Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate?Starting at €8.20
-
GSK's Acquisition of Sirtris: Independence or Integration, Teaching Note
Stuart, TobyTeaching Note HBS-811012-EEntrepreneurshipTeaching Note for 809026.Starting at €0.00
-
GSK's Acquisition of Sirtris: Independence or Integration
Stuart, Toby; Weber, JamesCase HBS-809026-EEntrepreneurshipAn executive from pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's Global head of R&D, championed the acquisition of Sirtris to gain access to its potentially revolutionary science. Slaoui must balance the need to recoup shareholder value after paying a two-times premium for Sirtris with his desire to retain Christoph Westphal, Sirtris's co-founder and CEO, and othe...Starting at €8.20
-
Sirtis Pharmaceuticals: Living Healthier, Longer, Teaching Note
Stuart, TobyTeaching Note HBS-809050-EEntrepreneurshipTeaching Note for [808-112].Starting at €0.00